We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
FMC Corp (FMC) Earnings and Revenues Surpass Estimates in Q2
Read MoreHide Full Article
FMC Corporation (FMC - Free Report) recorded earnings (as reported) of $1.56 per share in second-quarter 2021, up 11% from $1.41 reported a year ago.
Barring one-time items, adjusted earnings per share were $1.81, ahead of the Zacks Consensus Estimate of $1.77.
Revenues were $1,242 million for the quarter, up around 8% from the year-ago quarter. It surpassed the Zacks Consensus Estimate of $1,228 million.
Revenues were driven by a 4% rise in volumes and 4% favorable impact of currencies. The company saw strong volume growth in all regions outside of EMEA (Europe, Middle East, and Africa) on the back of strong underlying business and contribution of new product launches.
Sales dropped 7% year over year in North America in the quarter, impacted by a shift in volume demand by geography from the company’s global diamide partnerships.
Sales in Latin America went up 15% year over year in the reported quarter on strong demand for insecticide and fungicide, aided by favorable commodity prices, and favorable currency swings.
In EMEA, sales rose 3% year over year as higher demand for diamides and herbicides and favorable currency swings were offset by the impacts of unfavorable weather and discontinued registrations.
Revenues climbed 20% year over year in Asia on the back of strength in the insecticide portfolio, especially in India and Australia, and favorable impact of currencies.
Financials
The company had cash and cash equivalents of $728.5 million at the end of the quarter, up roughly 113% year over year. Long-term debt was $2,630.8 million, down around 13% year over year.
The company repurchased shares worth $25 million in the second quarter.
Guidance
For 2021, FMC continues to expect revenues to be between $4.9 billion and $5.1 billion, indicating a rise of 8% at the midpoint versus 2020. The growth is expected to be driven mainly by volumes and price increases.
The company now envisions adjusted EBITDA of $1.29-$1.35 billion (down from earlier view of $1.32-$1.42 billion) for 2021, indicating a 6% rise at the midpoint versus 2020. The revision reflects continued increase in raw materials, packaging and logistics costs.
Moreover, FMC now expects adjusted earnings per share for 2021 in the range of $6.54 to $6.94 (down from $6.70-$7.40 expected earlier), reflecting an increase of 9% at the midpoint compared with 2020.
Free cash flow for 2021 is now projected to be $480-$570 million, indicating a 4% year-over-year decline.
The company also expects to buyback $350-$450 million shares in 2021.
For third-quarter 2021, revenues are projected in the band of $1.13-$1.22 billion, reflecting an increase of 8% at the midpoint compared with the prior-year quarter. Adjusted earnings are forecast in the range of $1.23-$1.39 per share, representing an increase of 7% at the midpoint compared with the prior-year quarter.
Price Performance
FMC’s shares are down 0.7% over a year against the industry’s 37% rise
Image: Bigstock
FMC Corp (FMC) Earnings and Revenues Surpass Estimates in Q2
FMC Corporation (FMC - Free Report) recorded earnings (as reported) of $1.56 per share in second-quarter 2021, up 11% from $1.41 reported a year ago.
Barring one-time items, adjusted earnings per share were $1.81, ahead of the Zacks Consensus Estimate of $1.77.
Revenues were $1,242 million for the quarter, up around 8% from the year-ago quarter. It surpassed the Zacks Consensus Estimate of $1,228 million.
Revenues were driven by a 4% rise in volumes and 4% favorable impact of currencies. The company saw strong volume growth in all regions outside of EMEA (Europe, Middle East, and Africa) on the back of strong underlying business and contribution of new product launches.
FMC Corporation Price, Consensus and EPS Surprise
FMC Corporation price-consensus-eps-surprise-chart | FMC Corporation Quote
Regional Sales Performance
Sales dropped 7% year over year in North America in the quarter, impacted by a shift in volume demand by geography from the company’s global diamide partnerships.
Sales in Latin America went up 15% year over year in the reported quarter on strong demand for insecticide and fungicide, aided by favorable commodity prices, and favorable currency swings.
In EMEA, sales rose 3% year over year as higher demand for diamides and herbicides and favorable currency swings were offset by the impacts of unfavorable weather and discontinued registrations.
Revenues climbed 20% year over year in Asia on the back of strength in the insecticide portfolio, especially in India and Australia, and favorable impact of currencies.
Financials
The company had cash and cash equivalents of $728.5 million at the end of the quarter, up roughly 113% year over year. Long-term debt was $2,630.8 million, down around 13% year over year.
The company repurchased shares worth $25 million in the second quarter.
Guidance
For 2021, FMC continues to expect revenues to be between $4.9 billion and $5.1 billion, indicating a rise of 8% at the midpoint versus 2020. The growth is expected to be driven mainly by volumes and price increases.
The company now envisions adjusted EBITDA of $1.29-$1.35 billion (down from earlier view of $1.32-$1.42 billion) for 2021, indicating a 6% rise at the midpoint versus 2020. The revision reflects continued increase in raw materials, packaging and logistics costs.
Moreover, FMC now expects adjusted earnings per share for 2021 in the range of $6.54 to $6.94 (down from $6.70-$7.40 expected earlier), reflecting an increase of 9% at the midpoint compared with 2020.
Free cash flow for 2021 is now projected to be $480-$570 million, indicating a 4% year-over-year decline.
The company also expects to buyback $350-$450 million shares in 2021.
For third-quarter 2021, revenues are projected in the band of $1.13-$1.22 billion, reflecting an increase of 8% at the midpoint compared with the prior-year quarter. Adjusted earnings are forecast in the range of $1.23-$1.39 per share, representing an increase of 7% at the midpoint compared with the prior-year quarter.
Price Performance
FMC’s shares are down 0.7% over a year against the industry’s 37% rise
Image Source: Zacks Investment Research
Zacks Rank & Key Picks
FMC currently carries a Zacks Rank #4 (Sell).
Better-ranked stocks worth considering in the basic materials space include Nucor Corporation (NUE - Free Report) , ArcelorMittal (MT - Free Report) and Cabot Corporation (CBT - Free Report) , each sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Nucor has a projected earnings growth rate of 444.9% for the current year. The company’s shares have surged around 148% in a year.
ArcelorMittal has an expected earnings growth rate of 1,635.1% for the current year. The company’s shares have shot up around 206% in the past year.
Cabot has an expected earnings growth rate of around 137.5% for the current fiscal. The company’s shares have gained roughly 47% in the past year.